Company Filing History:
2 out of 5,470 
1 out of 13 
1 out of 28 Years Active: 2019-2022
Title: Innovations by Nicolas G H Ongenae
Introduction
Nicolas G H Ongenae is a notable inventor based in Ghent, Belgium. He has made significant contributions to the field of biotechnology, particularly in the development of FcRn antagonists. With a total of 2 patents, Ongenae's work focuses on innovative methods for treating antibody-mediated disorders.
Latest Patents
Ongenae's latest patents include compositions of novel FcRn antagonists. These compositions comprise a variant Fc region that binds specifically to FcRn with increased affinity and reduced pH dependence compared to the native Fc region. Additionally, the patents describe FcRn antagonists with enhanced CD16 binding affinity. The methods outlined in these patents provide approaches for treating antibody-mediated disorders, such as autoimmune diseases, using these FcRn antagonist compositions. The patents also cover nucleic acids encoding the FcRn antagonist compositions, recombinant expression vectors, and host cells for producing these compositions, as well as pharmaceutical formulations that incorporate them.
Career Highlights
Throughout his career, Ongenae has worked with prominent organizations, including the University of Texas System and Argenx Bvba. His experience in these institutions has contributed to his expertise in the field of biotechnology and patent development.
Collaborations
Ongenae has collaborated with notable colleagues such as Peter Ulrichts and Christophe Blanchetot. These partnerships have likely enhanced his research and development efforts in the field.
Conclusion
Nicolas G H Ongenae is a distinguished inventor whose work on FcRn antagonists has the potential to impact the treatment of autoimmune diseases significantly. His contributions to biotechnology and patent development are noteworthy and reflect his commitment to innovation.